Home > Insider Trading > Filing (0001415889-25-008517)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1806952	Lyell Immunopharma Inc.	LYEL	Pharmaceutical Preparations (2834)	833006753

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1866219	W. Charles Newton	C/O Lyell Immunopharma, Inc. 201 Haskins Way South San Francisco CA 94080	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-17	200,000	$0.56	200,000	No	4	P	Indirect	Co-grantor and Co-trustee

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Co-grantor and Co-trustee

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	172,725	Direct

Footnotes

The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.54 to $0.56, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range
Shares held by The Charles & Lisa Newton Living Trust. The Reporting Person is co-trustee and co-grantor of The Charles & Lisa Newton Living Trust.